Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Surmodics Inc (SRDX)

Surmodics Inc (SRDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Surmodics Inc 9924 WEST 74TH STREET EDEN PRAIRIE MN 55344 USA

www.surmodics.com Employees: 389 P: 952-500-7000 F: 952-500-7001

Sector:

Medical

INDUSTRY GROUPING:

Medical Products

Description:

Surmodics is a leading provider of medical device and In Vitro Diagnostics (IVD) technologies to the healthcare industry. It reports through two divisions: Medical Devices & IVD.'The Medical Devices segment comprises surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device, with end markets that include coronary, peripheral, neuro-vascular and urology, among others. The IVD segment includes component products and technologies for diagnostic test kits and biomedical research applications, with products that include protein stabilization reagents, substrates, antigens and surface coatings.

Key Statistics

Overview:

Market Capitalization, $K 614,528
Enterprise Value, $K 607,958
Shares Outstanding, K 14,298
Annual Sales, $ 126,080 K
Annual Net Income, $ -11,540 K
Last Quarter Sales, $ 29,570 K
Last Quarter Net Income, $ -5,320 K
EBIT, $ -8,840 K
EBITDA, $ 160 K
60-Month Beta 1.30
% of Insider Shareholders 8.90%
% of Institutional Shareholders 96.63%
Float, K 13,025
% Float 91.10%
Short Interest 475
Short Float 0.00%
Short Volume Ratio 0.59

Growth:

1-Year Return 9.50%
3-Year Return 19.32%
5-Year Return 12.04%
5-Year Revenue Growth 25.98%
5-Year Earnings Growth -144.44%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.06 on 08/08/25
Next Earnings Date 11/26/25
Earnings Per Share ttm -0.24
EPS Growth vs. Prev Qtr 146.15%
EPS Growth vs. Prev Year 122.22%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 2-1 on 12/07/00

SRDX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -2.99%
Return-on-Assets % -1.99%
Profit Margin % -9.15%
Debt/Equity 0.27
Price/Sales 5.07
Price/Cash Flow 138.92
Price/Book 5.52
Book Value/Share 7.78
Interest Coverage -1.12
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar